EMIT 2000 Mycophenolic Acid Assay*
MPA concentrations are highly variable in patients receiving the drug. As such, treatment needs to be individualized depending on transplant type, co-administrated drugs, time post transplant, and other factors. The EMIT® 2000 MPA assay is a simple, easy-to-use solution to help clinicians better manage MPA therapy in transplant patients.
Features
- Results available within 10 minutes
- Utilizes plasma samples - no pretreatment required
- Assay can be performed alongside 3 other immunosuppressive drugs
- Correlates to the HPLC reference method
Advantages
- Streamlined ISD monitoring for enhanced productivity
- Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® drug testing system
Assay Specifications
| EMIT 2000 MPA Assay | |
|---|---|
| Product Code | 6R919UL |
| Sample Type | EDTA or Heparinized plasma |
| Pretreatment | None |
| Reportable Range | 0.1 μg/mL–15 μg/mL |
| Calibration | With new reagent lot |
| Reagent Stability | Opened - until expiration date |
Learn more about the V-Twin® and Viva-E® Drug Testing Systems
Enduring Expertise for Your Immunosuppressant Drug Testing Needs
With recognized drug testing expertise, Siemens Healthcare Diagnostics offers a comprehensive and expanding menu of tests across multiple instrument solutions to meet the immunosuppressant drug (ISD) testing needs of customers in any setting.
Compartilhe esta página:
*Not available for sale in the U.S.
O produto/recurso exibido nesta página Web não está comercialmente disponível em todos os países. Por razões de regulamentação, sua disponibilidade futura não pode ser garantida. Por favor, entre em contato com a organização da Siemens local para maiores detalhes.